Eric Feinstein, Mba

CEO at Clarapath | Innovation & investment in healthcare and medical robotics

📍 New York City Metropolitan Area, United States🔄 Updated September 2026💼 5 investments📅 10 years investing🗓 Last invested Jan 2018
VC🌍 United States
5
Total investments
0
Early stage
4
Mid stage
1
Late stage
10y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Observer
2018
Gauss is the leader in computer vision in healthcare. Founded in 2011, Gauss’s mission is to digitally augment clinicians with software that radically improves diagnostic accuracy and leads to improved patient safety and clinical outcomes. Gauss’s flagship product, Triton, leverages computer vision to detect surgical and obstetric hemorrhage in real time and notifies clinicians who can enact timely intervention and treatment. Triton was granted De Novo clearance from the U.S. Food and Drug Administration (FDA) in 2014, as the first-ever computer vision software for surgical use, and several follow-on 510(k) clearances. Available on the iPhone, Triton has been widely adopted by health systems in the United States and is a recipient of the Apple Design Award, which recognizes the best in design, innovation and technology on Apple platforms. Gauss was acquired by Stryker (NYSE: SYK) in 2021. For more information, visit http://www.gauss.com.
Investor & Board Observer
2018
Please visit pressganey.com to learn more about our online reputation tools.
Investor & Board Observer
2017
Conversa is a leader in automated virtual health at scale. Conversa’s Automated Virtual Care and Triage™ platform utilizes its proprietary patient profiling and health signals engine, and an extensive library of evidence-based automated Conversational Care™ pathways, to help healthcare organizations effectively and efficiently risk stratify and remotely manage patients across the care continuum. Leading health systems, payers, employers and pharmaceutical companies are using Conversa to develop meaningful relationships and drive better health outcomes.
Investor & Board Observer
2016
PurpleSun is a venture backed commercial healthcare technology company based out of New York. We are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention. Our company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Our goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Our clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.
Investor & Board Member
2016
PurpleSun is a venture backed commercial healthcare technology company based out of New York. We are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention. Our company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Our goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Our clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.
Experience · 8 entries
All (8)
Investments (5)
Board (5)
2018
Investor & Board Observer
2018
Gauss is the leader in computer vision in healthcare. Founded in 2011, Gauss’s mission is to digitally augment clinicians with software that radically improves diagnostic accuracy and leads to improved patient safety and clinical outcomes. Gauss’s flagship product, Triton, leverages computer vision to detect surgical and obstetric hemorrhage in real time and notifies clinicians who can enact timely intervention and treatment. Triton was granted De Novo clearance from the U.S. Food and Drug Administration (FDA) in 2014, as the first-ever computer vision software for surgical use, and several follow-on 510(k) clearances. Available on the iPhone, Triton has been widely adopted by health systems in the United States and is a recipient of the Apple Design Award, which recognizes the best in design, innovation and technology on Apple platforms. Gauss was acquired by Stryker (NYSE: SYK) in 2021. For more information, visit http://www.gauss.com.
Investor & Board Observer
2018
Please visit pressganey.com to learn more about our online reputation tools.
2017
Investor & Board Observer
2017
Conversa is a leader in automated virtual health at scale. Conversa’s Automated Virtual Care and Triage™ platform utilizes its proprietary patient profiling and health signals engine, and an extensive library of evidence-based automated Conversational Care™ pathways, to help healthcare organizations effectively and efficiently risk stratify and remotely manage patients across the care continuum. Leading health systems, payers, employers and pharmaceutical companies are using Conversa to develop meaningful relationships and drive better health outcomes.
2016
Investor & Board Observer
2016
PurpleSun is a venture backed commercial healthcare technology company based out of New York. We are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention. Our company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Our goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Our clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.
Investor & Board Member
2016
PurpleSun is a venture backed commercial healthcare technology company based out of New York. We are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention. Our company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Our goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Our clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.
Show all 8 entries ↓
Investment activity
2016–2018 · 5 investments
201622017120182
Recent (last 2 years)Earlier